98 related articles for article (PubMed ID: 2115641)
21. Rapid GDP release from Gs alpha in patients with gain and loss of endocrine function.
Iiri T; Herzmark P; Nakamoto JM; van Dop C; Bourne HR
Nature; 1994 Sep; 371(6493):164-8. PubMed ID: 8072545
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in the molecular biology of growth-hormone secreting human pituitary tumours.
Adams EF; Buchfelder M; Hüttner A; Moreth S; Fahlbusch R
Exp Clin Endocrinol; 1993; 101(1):12-6. PubMed ID: 8477819
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneous mutations in the gene encoding the alpha-subunit of the stimulatory G protein of adenylyl cyclase in Albright hereditary osteodystrophy.
Miric A; Vechio JD; Levine MA
J Clin Endocrinol Metab; 1993 Jun; 76(6):1560-8. PubMed ID: 8388883
[TBL] [Abstract][Full Text] [Related]
24. Glycoprotein hormone alpha-subunit production in somatotroph adenomas with and without Gs alpha mutations.
Harris PE; Alexander JM; Bikkal HA; Hsu DW; Hedley-Whyte ET; Klibanski A; Jameson JL
J Clin Endocrinol Metab; 1992 Sep; 75(3):918-23. PubMed ID: 1517386
[TBL] [Abstract][Full Text] [Related]
25. G-protein oncogenes in acromegaly.
Spada A; Vallar L
Horm Res; 1992; 38(1-2):90-3. PubMed ID: 1306524
[TBL] [Abstract][Full Text] [Related]
26. S111N mutation in the helical domain of human Gs(alpha) reduces its GDP/GTP exchange rate.
Brito M; Guzmán L; Romo X; Soto X; Hinrichs MV; Olate J
J Cell Biochem; 2002; 85(3):615-20. PubMed ID: 11968001
[TBL] [Abstract][Full Text] [Related]
27. [G-proteins and endocrine tumors. The example of acromegaly].
Chabre O
Rev Prat; 1994 May; 44(9):1177-83. PubMed ID: 7939340
[TBL] [Abstract][Full Text] [Related]
28. No evidence for oncogenic mutations in guanine nucleotide-binding proteins of human adrenocortical neoplasms.
Reincke M; Karl M; Travis W; Chrousos GP
J Clin Endocrinol Metab; 1993 Nov; 77(5):1419-22. PubMed ID: 8077343
[TBL] [Abstract][Full Text] [Related]
29. Activating mutations of the TSH receptor in differentiated thyroid carcinomas.
Russo D; Arturi F; Schlumberger M; Caillou B; Monier R; Filetti S; Suárez HG
Oncogene; 1995 Nov; 11(9):1907-11. PubMed ID: 7478621
[TBL] [Abstract][Full Text] [Related]
30. Regulation of G protein activation and effector modulation by fusion proteins between the human 5-hydroxytryptamine(1A) receptor and the alpha subunit of G(i1): differences in receptor-constitutive activity imparted by single amino acid substitutions in G(i1)alpha.
Kellett E; Carr IC; Milligan G
Mol Pharmacol; 1999 Oct; 56(4):684-92. PubMed ID: 10496950
[TBL] [Abstract][Full Text] [Related]
31. Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors.
Adams EF; Brockmeier S; Friedmann E; Roth M; Buchfelder M; Fahlbusch R
Neurosurgery; 1993 Aug; 33(2):198-203; discussion 203. PubMed ID: 8396223
[TBL] [Abstract][Full Text] [Related]
32. Gs alpha and Gi2 alpha mutations in clinically non-functioning pituitary tumours.
Williamson EA; Daniels M; Foster S; Kelly WF; Kendall-Taylor P; Harris PE
Clin Endocrinol (Oxf); 1994 Dec; 41(6):815-20. PubMed ID: 7889619
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic mutations of alpha-Gi2 protein are not determinant for human adrenocortical tumourigenesis.
Gicquel C; Dib A; Bertagna X; Amselem S; Le Bouc Y
Eur J Endocrinol; 1995 Aug; 133(2):166-72. PubMed ID: 7655640
[TBL] [Abstract][Full Text] [Related]
34. G protein abnormalities in pituitary adenomas.
Spada A; Lania A; Ballarè E
Mol Cell Endocrinol; 1998 Jul; 142(1-2):1-14. PubMed ID: 9783897
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of gsp-positive growth hormone-secreting pituitary tumors in Korean acromegalic patients.
Yang I; Park S; Ryu M; Woo J; Kim S; Kim J; Kim Y; Choi Y
Eur J Endocrinol; 1996 Jun; 134(6):720-6. PubMed ID: 8766942
[TBL] [Abstract][Full Text] [Related]
36. Gs protein mutations and the pathogenesis and function of pituitary tumors.
Harris PE
Metabolism; 1996 Aug; 45(8 Suppl 1):120-2. PubMed ID: 8769404
[TBL] [Abstract][Full Text] [Related]
37. Clinical correlates in acromegalic patients with pituitary tumors expressing GSP oncogenes.
Buchfelder M; Fahlbusch R; Merz T; Symowski H; Adams EF
Pituitary; 1999 May; 1(3-4):181-5. PubMed ID: 11081196
[TBL] [Abstract][Full Text] [Related]
38. G-protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas.
Williamson EA; Ince PG; Harrison D; Kendall-Taylor P; Harris PE
Eur J Clin Invest; 1995 Feb; 25(2):128-31. PubMed ID: 7737262
[TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein.
Landis CA; Harsh G; Lyons J; Davis RL; McCormick F; Bourne HR
J Clin Endocrinol Metab; 1990 Dec; 71(6):1416-20. PubMed ID: 2121775
[TBL] [Abstract][Full Text] [Related]
40. GS protein mutations and pituitary tumors: functional correlates and possible therapeutic implications.
Faglia G; Arosio M; Spada A
Metabolism; 1996 Aug; 45(8 Suppl 1):117-9. PubMed ID: 8769403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
